Background: Bronchoplastic resections are now widely used as a surgical treatment for resectable central lung cancer. However, bronchial dehiscence is one of the most life-threatening complications, making it important to identify its risk factors to separate patients who require more attention during the postoperative period.
Methods: The data of 285 patients who underwent bronchoplasty from 2006 to 2021 were retrospectively reviewed.